He was the CEO of Serono, a company that was initially engaged in the manufacture of pharmaceuticals. He inherited the company from his father, who founded the company. He then started to focus on biotechnology, allowing the company to more than triple its profits in just 10 years. The company has since merged with Merck. He still handles Ares Life Sciences, a medical technology investment company.